B
Bull
Bull · 25%RACE
$514.99
Scenario price
$420.540
+6.602 (+1.57%)At close
Loading chart…
- High
- 425.730
- Open
- 422.760
- VWAP
- 421.64
- Vol
- 319.12K
- Mkt Cap
- 73.71B
- Low
- 418.650
- Amount
- 134.55M
- EV/EBITDA, TTM
- 19.98
Ferrari NV, known as Ferrari, is an Italy-based designer, manufacturer and retailer of sports cars that is incorporated in the Netherlands. It operates under the Ferrari brand. Its sports cars portfolio includes, among others, F12berlinetta, FF, Ferrari 488 GTB, 488 Spider, 458 Speciale, Ferrari California T, F12tdf and LaFerrari. The Company also offers financing services through Ferrari Financial Services. It also produces limited series and one-off cars. The Company divides its regional markets in EMEA (Europe, the Middle East, India and Africa), Americas, Greater China and Rest of APAC (Asia-Pacific region, excluding Greater China) and is active in over 60 markets worldwide through a network of authorized dealers.
AI analysis of Ferrari NV (RACE)
buyFerrari NV (RACE) is a good buy right now. The current price is $420.54, which is below several analyst price targets, including $442 from Morgan Stanley and $460 from Bernstein. Additionally, the company has shown strong revenue growth, with Q2 2026 revenue reaching EUR 1.94 billion, and a solid gross margin of 52.59%. However, the main risk is the recent 1-year change of -14.54%, indicating potential volatility.
Analyst Ratings (10)
+6.73% upside
Buy
4 Buy
3 Hold
3 Sell
Current: 420.54
Low
349.74
Average
448.83
High
555.00
Berenberg
Buy
—
2026-08-03
Berenberg
2026-08-03
Price Target
—
Buy
Citi
Neutral
—
2026-08-03
Citi
2026-08-03
Price Target
—
Neutral
Morgan Stanley
Overweight
$442
2026-07-31
Morgan Stanley
2026-07-31
Price Target
$442
Overweight
Bernstein
Outperform
$460
2026-07-31
Bernstein
2026-07-31
Price Target
$460
Outperform
Wolfe Research
Outperform
—
2026-07-07
Wolfe Research
2026-07-07
Price Target
—
Outperform
Valuation Metrics
The current forward P/E ratio for Ferrari NV (RACE) is 35.59, compared to its 5-year average forward P/E of 42.00.
Alphio AI Price Scenarios for RACE
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding RACE
Events Timeline
News
4.508-28Yahoo FinanceEuropean Stock Markets Close Higher on Friday
8.508-25CNBCBugatti Rimac's Mate Rimac Discusses Supercar Market Transformation
4.508-23Yahoo FinanceMonterey Car Week Reveals K-Shaped Luxury Market Dynamics
8.508-17Yahoo FinanceFerrari's Electric Vehicle Auction Sets Record at $40 Million
2.008-17NewsfilterFerrari's First Electric Vehicle Auction Sets Record at $40 Million
RACE FAQ — answered by Alphio AI
Ferrari NV, known as Ferrari, is an Italy-based designer, manufacturer and retailer of sports cars that is incorporated in the Netherlands. It operates under the Ferrari brand. Its sports cars portfolio includes, among others, F12berlinetta, FF, Ferrari 488 GTB, 488 Spider, 458 Speciale, Ferrari California T, F12tdf and LaFerrari. The Company also offers financing services through Ferrari Financial Services. It also produces limited series and one-off cars. The Company divides its regional markets in EMEA (Europe, the Middle East, India and Africa), Americas, Greater China and Rest of APAC (Asia-Pacific region, excluding Greater China) and is active in over 60 markets worldwide through a network of authorized dealers. It operates in the Consumer Cyclicals sector.
Ferrari NV (RACE) is a good buy right now. The current price is $420.54, which is below several analyst price targets, including $442 from Morgan Stanley and $460 from Bernstein. Additionally, the company has shown strong revenue growth, with Q2 2026 revenue reaching EUR 1.94 billion, and a solid gross margin of 52.59%. However, the main risk is the recent 1-year change of -14.54%, indicating potential volatility.
10 analysts cover RACE: 4 rate it Buy, 3 Hold and 3 Sell. The average price target is 448.83.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.